• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有肿瘤芽生的乳腺癌的组织病理学和分子特征:系统评价和荟萃分析。

The histopathological and molecular features of breast carcinoma with tumour budding-a systematic review and meta-analysis.

机构信息

Department of Surgery, Galway University Hospital, Galway, Ireland.

Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.

出版信息

Breast Cancer Res Treat. 2020 Oct;183(3):503-514. doi: 10.1007/s10549-020-05810-3. Epub 2020 Jul 24.

DOI:10.1007/s10549-020-05810-3
PMID:32710280
Abstract

PURPOSE

Tumour budding (TB) is an adverse histological feature in many epithelial cancers. It is thought to represent epithelial-mesenchymal transition, a key step in the metastatic process. The significance of TB in breast carcinoma (BC) remains unclear. The aim of this study is to investigate the relationship between TB and other histological and molecular features of BC.

METHODS

A systematic search was performed to identify studies that compared features of BC based on the presence or absence of high-grade TB. Dichotomous variables were pooled as odds ratios (OR) using the Der Simonian-Laird method. Quality assessment of the included studies was performed using the Newcastle-Ottawa scale (NOS).

RESULTS

Seven studies with a total of 1040 patients (high-grade TB n = 519, 49.9%; low-grade/absent TB n = 521, 50.1%) were included. A moderate to high risk of bias was noted. The median NOS was 7 (range 6-8). High-grade TB was significantly associated with lymph node metastasis (OR 2.32, 95% c.i. 1.77 to 3.03, P < 0.001) and lymphovascular invasion (OR 3.08, 95% c.i. 2.13 to 4.47, P < 0.001). With regard to molecular subtypes, there was an increased likelihood of high-grade TB in oestrogen (OR 1.66, 95% c.i. 1.21 to 2.29, P = 0.002) and progesterone receptor-positive (OR 1.48, 95% c.i. 1.09 to 2.02, P = 0.01) tumours. In contrast, triple-negative breast cancer had a reduced incidence of high-grade TB (OR 0.46, 95% c.i. 0.30 to 0.72, P = 0.0006).

CONCLUSION

High-grade TB is enriched in hormone receptor-positive BC and is associated with known adverse prognostic variables. TB may offer new insights into the metastatic process of BC.

摘要

目的

肿瘤芽(TB)是许多上皮癌的不良组织学特征。它被认为代表上皮-间充质转化,这是转移过程中的关键步骤。TB 在乳腺癌(BC)中的意义尚不清楚。本研究旨在探讨 TB 与 BC 的其他组织学和分子特征之间的关系。

方法

系统检索以确定比较基于高分级 TB 存在与否的 BC 特征的研究。使用 Der Simonian-Laird 方法将二项变量汇总为优势比(OR)。使用纽卡斯尔-渥太华量表(NOS)对纳入研究进行质量评估。

结果

纳入了 7 项共 1040 例患者的研究(高分级 TB 组 n=519,49.9%;低分级/无 TB 组 n=521,50.1%)。存在中度至高度偏倚风险。NOS 的中位数为 7(范围 6-8)。高分级 TB 与淋巴结转移(OR 2.32,95%置信区间 1.77 至 3.03,P<0.001)和淋巴管侵犯(OR 3.08,95%置信区间 2.13 至 4.47,P<0.001)显著相关。关于分子亚型,高分级 TB 在雌激素受体(OR 1.66,95%置信区间 1.21 至 2.29,P=0.002)和孕激素受体阳性(OR 1.48,95%置信区间 1.09 至 2.02,P=0.01)肿瘤中更常见。相反,三阴性乳腺癌的高分级 TB 发生率较低(OR 0.46,95%置信区间 0.30 至 0.72,P=0.0006)。

结论

高分级 TB 在激素受体阳性 BC 中更为丰富,与已知的不良预后变量相关。TB 可能为 BC 的转移过程提供新的见解。

相似文献

1
The histopathological and molecular features of breast carcinoma with tumour budding-a systematic review and meta-analysis.伴有肿瘤芽生的乳腺癌的组织病理学和分子特征:系统评价和荟萃分析。
Breast Cancer Res Treat. 2020 Oct;183(3):503-514. doi: 10.1007/s10549-020-05810-3. Epub 2020 Jul 24.
2
Tumor budding in breast carcinoma: A systematic review and meta-analysis.乳腺癌中的肿瘤芽生:系统评价和荟萃分析。
J Cancer Res Ther. 2023 Oct 1;19(7):1697-1713. doi: 10.4103/jcrt.jcrt_188_22. Epub 2023 Apr 25.
3
Tumour budding in invasive breast carcinoma of no special type - relationship with clinicopathological parameters.非特殊型浸润性乳腺癌的肿瘤芽-与临床病理参数的关系。
Pol J Pathol. 2024;75(2):77-82. doi: 10.5114/pjp.2024.139272.
4
Tumour budding in invasive breast carcinoma and its correlation with histopathological prognostic parameters and hormone receptor status.浸润性乳腺癌中的肿瘤芽及其与组织病理学预后参数和激素受体状态的相关性。
J Cancer Res Ther. 2023 Jan 1;19(Suppl 2):S664-S668. doi: 10.4103/jcrt.jcrt_656_22. Epub 2023 Apr 28.
5
Molecular subtypes of invasive breast carcinoma of no special type, their correlation with histopathological features, Ki 67 index and tumor budding: A retrospective comparative study.非特殊型浸润性乳腺癌的分子亚型及其与组织病理学特征、Ki-67 指数和肿瘤芽的相关性:一项回顾性对比研究。
Indian J Pathol Microbiol. 2022 Oct-Dec;65(4):772-780. doi: 10.4103/ijpm.ijpm_90_21.
6
Tumour budding is a novel marker in breast cancer: the clinical application and future prospects.肿瘤芽生是乳腺癌的一个新标志物:临床应用和未来前景。
Ann Med. 2022 Dec;54(1):1303-1312. doi: 10.1080/07853890.2022.2070272.
7
Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.根据国际肿瘤芽生共识会议标准评估的胃癌肿瘤芽生的预后意义。
Histopathology. 2020 Feb;76(3):433-446. doi: 10.1111/his.13997. Epub 2019 Dec 1.
8
Tumour budding in invasive ductal breast carcinomas: correlation with clinicopathological prognostic parameters and hormone receptor status.浸润性导管癌中的肿瘤芽生:与临床病理预后参数及激素受体状态的相关性
Pathol Oncol Res. 2025 Feb 12;31:1611983. doi: 10.3389/pore.2025.1611983. eCollection 2025.
9
Clinicopathological Significance of Tumor Budding in Breast Carcinoma.乳腺癌中肿瘤出芽的临床病理意义。
J Nepal Health Res Counc. 2024 Mar 22;21(3):417-427. doi: 10.33314/jnhrc.v21i3.4538.
10
Prognostic Significance of "High" Tumor Budding and "High" Poorly Differentiated Clusters in Endometrial Carcinomas: Independent Predictors of Lymphovascular Space Invasion and Lymph Node Metastasis.子宫内膜癌中“高”肿瘤芽生与“高”低分化簇的预后意义:淋巴管间隙浸润和淋巴结转移的独立预测因素
Int J Gynecol Pathol. 2025 May 1;44(3):222-229. doi: 10.1097/PGP.0000000000001061. Epub 2024 Jul 29.

引用本文的文献

1
Tumor budding in invasive breast carcinoma and its association with clinicopathological parameters: an experience from a tertiary care center in India.浸润性乳腺癌中的肿瘤芽生及其与临床病理参数的关系:来自印度一家三级医疗中心的经验。
Korean J Clin Oncol. 2025 Apr;21(1):13-19. doi: 10.14216/kjco.24317. Epub 2025 Apr 30.
2
Tumor Budding: A Novel Prognostic Marker in Breast Carcinoma with Correlation of Histopathological and Immunohistochemical Parameters.肿瘤芽生:乳腺癌中的一种新型预后标志物及其与组织病理学和免疫组化参数的相关性
South Asian J Cancer. 2024 Aug 28;14(1):38-44. doi: 10.1055/s-0044-1789582. eCollection 2025 Jan.
3
The relationship between tumor budding and survival of patients with breast cancer: A meta-analysis.
肿瘤芽生与乳腺癌患者生存的关系:一项荟萃分析。
Biomol Biomed. 2024 Oct 17;24(6):1546-1558. doi: 10.17305/bb.2024.11103.
4
The impact of tumor budding and single-cell invasion on survival in patients with stage III/IV locally advanced oral squamous cell carcinoma- results from a prospective cohort study.肿瘤芽生和单细胞侵袭对Ⅲ/Ⅳ期局部晚期口腔鳞状细胞癌患者生存的影响——一项前瞻性队列研究的结果
Front Oncol. 2024 Apr 29;14:1404361. doi: 10.3389/fonc.2024.1404361. eCollection 2024.
5
Two Cases of Lymph Node Metastasis Found in Differentiated, Small-Sized Gastric Adenocarcinomas: Did Tumor Budding Play a Critical Role?分化型小胃腺癌中发现的 2 例淋巴结转移:肿瘤芽在其中发挥了关键作用吗?
Medicina (Kaunas). 2023 Dec 5;59(12):2126. doi: 10.3390/medicina59122126.
6
MRI-based radiomic models to predict surgical margin status and infer tumor immune microenvironment in breast cancer patients with breast-conserving surgery: a multicenter validation study.基于MRI的放射组学模型预测保乳手术乳腺癌患者手术切缘状态及推断肿瘤免疫微环境:一项多中心验证研究
Eur Radiol. 2024 Mar;34(3):1774-1789. doi: 10.1007/s00330-023-10144-x. Epub 2023 Sep 2.
7
Tumour budding is a novel marker in breast cancer: the clinical application and future prospects.肿瘤芽生是乳腺癌的一个新标志物:临床应用和未来前景。
Ann Med. 2022 Dec;54(1):1303-1312. doi: 10.1080/07853890.2022.2070272.
8
Tumor Budding in Gynecologic Cancer as a Marker for Poor Survival: A Systematic Review and Meta-Analysis of the Perspectives of Epithelial-Mesenchymal Transition.妇科癌症中的肿瘤芽生作为生存不良的标志物:上皮-间质转化视角的系统评价和荟萃分析
Cancers (Basel). 2022 Mar 10;14(6):1431. doi: 10.3390/cancers14061431.
9
Prognostic Role of Tumor Budding in Breast Cancer Patients Receiving Neo-Adjuvant Therapy.肿瘤芽生在接受新辅助治疗的乳腺癌患者中的预后作用
J Clin Med. 2021 Feb 18;10(4):827. doi: 10.3390/jcm10040827.